Page 7 - HFA Dateline 2020-2021 Special Issue
P. 7

COVID-19 VACCINES


                           DON’T STOP EMERGING


               THERAPY OPTIONS FOR THOSE


                   WITH BLEEDING DISORDERS




                                     BY HFA STAFF WITH SCIENTIFIC REVIEW
                                  BY DR. DAVID CLARK AND DR. LISA HENSLEY

        Many people have questions about the COVID-19  against them. The first dose of the vaccine starts this
        vaccines. This article will answer one primary question:  process and provides some protection. The second
        Can getting vaccinated for COVID-19 cut off            dose raises  and refines that protection to about
        treatment options for emerging bleeding  disorder  95% and helps the effects of the vaccine last longer.
        treatments and therapies?  Of the three vaccines  The refinement is like the second time you play an
        currently available in the United States, the Pfizer and  opponent in a sport: Even if they change some of their
        Moderna  vaccines  use  messenger  ribonucleic  acid  strategy, you are better able to handle them.
        (mRNA) technology while the Johnson & Johnson
        vaccine uses a viral vector.                           The Johnson & Johnson vaccine works differently,
                                                               using something called a “viral vector.” A viral vector
        HOW THESE VACCINES WORK                                is created when scientists take a nonpathogenic

        The virus that causes COVID-19 is called SARS-CoV-2,  virus (that doesn’t make humans sick) and alter it
        which is a coronavirus. Coronaviruses have protein  to do something different. For the vaccine, Johnson
        spikes sticking out of them that allow the virus to  &  Johnson  took  an adenovirus  and  replaced  part  of
        attach to and enter cells. All three vaccines use that  its genetic instructions with the genes to create the
        spike protein to help our bodies develop an immune  SARS-CoV-2 spike protein. When you get the shot, the
        response to prevent illness.                           adenovirus enters your cells, giving them the genetic
                                                               instructions to make the spike protein. Once those
        In the case of the mRNA vaccines, when you get the     spike proteins start appearing on the surfaces of your
        shot, mRNA goes into cells and sends “instructions” to   cells, your immune system recognizes them as foreign
        the cells to create the spike protein. By itself, the spike   and builds an immune response against them. As with
        protein will not cause COVID-19 — it’s just one piece   the mRNA, the viral vector with the DNA in it only lasts
        of the virus. The mRNA lasts in your system for about   a short time. This is because the viral vector does not
        24 hours and then starts to degrade, but your cells will   replicate well, so it also degrades out of the body. The
        continue to express the spike proteins for a few days.   Johnson & Johnson vaccine requires only one dose at
        Your immune system recognizes those spike proteins     this time.
        as foreign and starts creating an immune response

                                                                                             SPECIAL ISSUE 2021         7
   2   3   4   5   6   7   8   9   10   11   12